Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
41
PRTA Quote, Financials, Valuation and Earnings
Last price:
$11.15
Seasonality move
:
0%
Day range:
$10.95 - $11.57
52-week range:
$4.32 - $17.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
50.97x
P/B ratio:
2.04x
Volume:
1.2M
Avg. volume:
594.6K
1-year change:
-23.19%
Market cap:
$600.7M
Revenue:
$135.2M
EPS (TTM):
-$5.21
Analysts' Opinion
-
Consensus RatingProthena Corp. Plc has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 2 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $20.33, Prothena Corp. Plc has an estimated upside of 82.2% from its current price of $11.16.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.00 representing 100% downside risk from its current price of $11.16.
Fair Value
-
According to the consensus of 4 analysts, Prothena Corp. Plc has 82.2% upside to fair value with a price target of $20.33 per share.
PRTA vs. S&P 500
-
Over the past 5 trading days, Prothena Corp. Plc has overperformed the S&P 500 by 6.87% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Prothena Corp. Plc does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Prothena Corp. Plc has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Prothena Corp. Plc reported revenues of $2.4M.
Earnings Growth
-
Prothena Corp. Plc has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Prothena Corp. Plc reported earnings per share of -$0.68.
Enterprise value:
279M
EV / Invested capital:
0.92x
Price / LTM sales:
50.97x
EV / EBIT:
--
EV / Revenue:
23.67x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
-1.46x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$8.1M
Return On Assets:
-58.69%
Net Income Margin (TTM):
-2379.59%
Return On Equity:
-67.47%
Return On Invested Capital:
-65.85%
Operating Margin:
-1646.42%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $141M | $133.4M | $11.8M | $970K | $2.4M | |
| Gross Profit | $133.4M | $116.4M | $8.1M | $78K | $1.5M | |
| Operating Income | -$112.6M | -$168.2M | -$222.2M | -$66.5M | -$39.8M | |
| EBITDA | -$105M | -$151.2M | -$218.6M | -$65.6M | -$38.8M | |
| Diluted EPS | -$1.43 | -$2.48 | -$5.21 | -$1.10 | -$0.68 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $607.5M | $524.6M | $690.6M | $535M | $340M | |
| Total Assets | $632.7M | $554.4M | $746.9M | $595.3M | $352.6M | |
| Current Liabilities | $29.2M | $50.6M | $53.4M | $46.4M | $51.4M | |
| Total Liabilities | $142.2M | $149.8M | $129.7M | $60.9M | $57.6M | |
| Total Equity | $490.5M | $404.6M | $617.2M | $534.4M | $295M | |
| Total Debt | $13.8M | $1.6M | $8.9M | $8.9M | $6.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$91.2M | -$153.1M | -$191.3M | -$46.5M | -$43.2M | |
| Cash From Investing | -$1.4M | -$1.7M | -$180.6K | -$12.6K | -$11.4K | |
| Cash From Financing | $259.8M | $1.6M | -$242.8K | $355K | -$18.7K | |
| Free Cash Flow | -$92.6M | -$154.9M | -$191.5M | -$46.5M | -$43.2M | |
PRTA
Sector
Market Cap
$600.7M
$28.4M
Price % of 52-Week High
63.19%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
0.16%
-1.32%
1-Year Price Total Return
-23.19%
-22.19%
Beta (5-Year)
-0.099
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$10.63
200-day SMA
Buy
Level
$9.13
Bollinger Bands (100)
Buy
Level
7.64 - 10.4
Chaikin Money Flow
Sell
Level
-28.9M
20-day SMA
Buy
Level
$10.44
Relative Strength Index (RSI14)
Buy
Level
61.40
ADX Line
Buy
Level
30.99
Williams %R
Neutral
Level
-22.5275
50-day SMA
Buy
Level
$10.25
MACD (12, 26)
Buy
Level
0.19
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
22.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.8848)
Buy
CA Score
(Annual)
Level (0.0739)
Buy
Beneish M-Score
(Annual)
Level (-2.4732)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.805)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Stock Forecast FAQ
In the current month, PRTA has received 2 Buy ratings 2 Hold ratings, and 0 Sell ratings. The PRTA average analyst price target in the past 3 months is $20.33.
-
Where Will Prothena Corp. Plc Stock Be In 1 Year?
According to analysts, the consensus estimate is that Prothena Corp. Plc share price will rise to $20.33 per share over the next 12 months.
-
What Do Analysts Say About Prothena Corp. Plc?
Analysts are divided on their view about Prothena Corp. Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Prothena Corp. Plc is a Sell and believe this share price will drop from its current level to $8.00.
-
What Is Prothena Corp. Plc's Price Target?
The price target for Prothena Corp. Plc over the next 1-year time period is forecast to be $20.33 according to 4 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is PRTA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Prothena Corp. Plc is a Leans Bullish. 2 of 4 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of PRTA?
You can purchase shares of Prothena Corp. Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Prothena Corp. Plc shares.
-
What Is The Prothena Corp. Plc Share Price Today?
Prothena Corp. Plc was last trading at $11.15 per share. This represents the most recent stock quote for Prothena Corp. Plc. Yesterday, Prothena Corp. Plc closed at $11.16 per share.
-
How To Buy Prothena Corp. Plc Stock Online?
In order to purchase Prothena Corp. Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get PRTA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PRTA
Sector
P/E ratio
--
23.66x
PEG ratio
-0.02x
-0.01x
P/B ratio
2.04x
1.84x
Price / LTM sales
50.97x
1.60x
Growth Metrics
PRTA
Sector
Revenue growth
148.97%
4.85%
Earnings growth
38.12%
11.15%
Revenue (5-year growth)
178%
6.45%
Earnings forecast
-$0.54
-$0.20
Profitability
PRTA
Sector
Profitability FY 2024
$131.6M
$3.6M
Return on invested capital
-65.85%
-30.98%
Return on assets
-58.69%
-27.62%
Return on equity
-67.47%
-36.69%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Feb
5
Balance Sheet
PRTA
Sector
Total cash
$330.8M
$27.2M
Short term investments
--
$25.7M
Total assets
$547.1M
$79.9M
Long term debt
$6.2M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
